Table 1 Baseline patient and tumor characteristics
Parameter | N | % |
|---|---|---|
Gender | ||
Male | 60 | 88.2 |
Female | 8 | 11.8 |
Smoking | ||
No | 22 | 32.4 |
Yes | 46 | 67.6 |
Lymph node density | ||
‹ 0.2 | 56 | 82.4 |
≥0.2 | 12 | 17.6 |
Adjuvant chemotherapy | ||
No | 51 | 75.0 |
Yes | 17 | 25.0 |
Neo-adjuvant chemotherapy | ||
No | 65 | 95.59 |
Yes | 3 | 4.41 |
Muscle invasion (4 missing) | ||
Non-muscle invasive | 13 | 20.3 |
Muscle invasive | 51 | 79.7 |
Grade at diagnosis | ||
Grade I | 9 | 13.2 |
Grade II | 13 | 19.1 |
Grade II | 46 | 67.6 |
Stage at diagnosis | ||
Stage I | 14 | 20.6 |
Stage II | 22 | 32.4 |
Stage III | 20 | 29.4 |
Stage IV | 12 | 17.6 |
T Stage | ||
T1 | 13 | 19.1 |
T2 | 30 | 44.1 |
T3 | 16 | 24.5 |
T4 | 9 | 13.3 |
N Stage | ||
N0 | 52 | 76.5 |
N1 | 10 | 14.7 |
N2 | 2 | 2.9 |
N3 | 4 | 5.9 |
Parameter | Mean ± SD |  |
Hemoglobin (g/dL) | 12.3 ± 1.72 |  |
WBC count (103/ul) | 7.7 ± 1.9 |  |
Platelets (103/ul) | 263.1 ± 90.7 |  |
LN density (among patients with LN involvement) | 37% (Range 12–100) |  |
Lymphocyte | 24.9 ± 7.9 |  |
|  | Range (6–46) |  |
Monocyte | 7.0 ± 2.4 |  |
|  | Range(2 – 12) |  |
LMR | 3.5 ± 1.9 |  |
|  | Range (1.38 – 11.50) |  |